These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29626491)

  • 1. A tetravalent vaccine comprising hexon-chimeric adenoviruses elicits balanced protective immunity against human adenovirus types 3, 7, 14 and 55.
    Tian X; Jiang Z; Fan Y; Qiu S; Zhang L; Li X; Zhou Z; Liu T; Ma Q; Lu X; Zhong B; Zhou R
    Antiviral Res; 2018 Jun; 154():17-25. PubMed ID: 29626491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon.
    Tian X; Su X; Li H; Li X; Zhou Z; Liu W; Zhou R
    Virus Res; 2011 Sep; 160(1-2):214-20. PubMed ID: 21740937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon.
    Su X; Tian X; Jiang Z; Ma Q; Liu Q; Lu X; Zhou R
    PLoS One; 2016; 11(6):e0156984. PubMed ID: 27328032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
    Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
    PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
    Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
    Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
    Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
    Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Vaccination with Replication-Competent Adenovirus in Mice Reveals Dissemination of the Viral Vaccine beyond the Gastrointestinal Tract.
    Goffin E; Javaux J; Destexhe E; Pretto CD; Spindler KR; Machiels B; Gillet L
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses.
    Hu K; Fu M; Guan X; Zhang D; Deng X; Xiao Y; Chen R; Liu H; Hu Q
    Vaccine; 2018 Jul; 36(29):4287-4297. PubMed ID: 29885770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing epitopes mapping of human adenovirus type 14 hexon.
    Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
    Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
    Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
    J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein.
    Tian X; Ma Q; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
    Viruses; 2015 Oct; 7(10):5632-42. PubMed ID: 26516903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
    J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity.
    Feng Y; Sun X; Ye X; Feng Y; Wang J; Zheng X; Liu X; Yi C; Hao M; Wang Q; Li F; Xu W; Li L; Li C; Zhou R; Chen L; Feng L
    Virology; 2018 May; 518():272-283. PubMed ID: 29550678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
    Bradley RR; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
    J Virol; 2012 Jan; 86(1):625-9. PubMed ID: 22072776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
    Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
    J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
    Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
    Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.
    Paris R; Kuschner RA; Binn L; Thomas SJ; Colloca S; Nicosia A; Cortese R; Bailer RT; Sullivan N; Koup RA
    Clin Vaccine Immunol; 2014 May; 21(5):783-6. PubMed ID: 24623627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of adenovirus neutralizing antigens using capsid chimeric viruses.
    Liu T; Fan Y; Li X; Gu S; Zhou Z; Xu D; Qiu S; Li C; Zhou R; Tian X
    Virus Res; 2018 Sep; 256():100-106. PubMed ID: 30096411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.